Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium.
Bradley
Deborah A
DA
Duke University, Durham, NC, USA [corrected].
Daignault
Stephanie
S
Ryan
Charles J
CJ
Dipaola
Robert S
RS
Cooney
Kathleen A
KA
Smith
David C
DC
Small
Eric
E
Mathew
Paul
P
Gross
Mitchell E
ME
Stein
Mark N
MN
Chen
Alice
A
Pienta
Kenneth J
KJ
Escara-Wilke
June
J
Doyle
Gerald
G
Al-Hawary
Mahmoud
M
Keller
Evan T
ET
Hussain
Maha
M